Wormwood for Anti-Inflammatory

Research suggests that wormwood and its related Artemisia species demonstrate meaningful anti-inflammatory activity across a range of laboratory and animal studies, with the evidence coming primarily from in vitro cell culture experiments, animal models, and a small number of narrative reviews rather than human clinical trials. Studies indicate that wormwood essential oils and extracts can suppress key inflammatory signaling pathways, including NF-κB activation and the expression of cytokines such as IL-6, IL-1β, and TNF-α, while isolated compounds from wormwood species, such as eupatilin and artemisinin, have shown effects comparable in some animal models to established non-steroidal anti-inflammatory drugs. Additional research has explored practical applications of these anti-inflammatory properties, including wound-healing formulations incorporating wormwood extracts that showed reduced inflammation and accelerated tissue repair in animal models, and one review noted that the anti-inflammatory properties of sweet wormwood may partly explain reported symptomatic relief in some patient populations. The overall direction of the available evidence is supportive, but the near-complete absence of controlled human trials means that whether these laboratory and animal findings translate to meaningful clinical benefit in people remains an open question.